Emcure Pharmaceuticals Limited has informed the Exchange about dispatch of letter to the Members whose e-mail addresses are not registered with the Company/Depository Participants.
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has dispatched letters to shareholders who have not registered their email addresses with the company or depository participants, providing web-links and a QR code to download the 44th AGM Notice and the Annual Report for FY 2024-25. The 44th Annual General Meeting is scheduled for Thursday, August 28, 2025 at 11:00 a.m. (IST) via Video Conferencing/Other Audio Visual Means. The cut-off date for identifying such shareholders was July 25, 2025. The letter also reminds shareholders to submit TDS exemption documents by August 21, 2025 to claim exemption on the Final Dividend for FY 2024-25 (subject to shareholder approval at the AGM), and to update KYC details and dematerialize physical holdings as per the latest SEBI Master Circular dated June 23, 2025.
This is a routine compliance filing under SEBI Listing Regulations with no direct impact on the stock price. It confirms the AGM date, makes annual report documents accessible to shareholders without registered emails, and reinforces key shareholder actions (TDS exemption submission, KYC updation, dematerialization) ahead of the AGM.